International CIPN Assessment and Validation Study (NCT04633655)

🧪 Interventions in This Study

• outcome measures for CIPN testing (OTHER)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (30 Sites)

Showing the first 25 of 30 sites.

• Birmingham School of Nursing, University of Alabama — Birmingham, Alabama
• Northside Hospital — Atlanta, Georgia
• JHU — Baltimore, Maryland
• University of Michigan School of Nursing — Ann Arbor, Michigan
• Columbia University Irving Medical Center — New York, New York
• Cancer Center/Wexner Medical Center - Ohio State Medical Oncology Division — Columbus, Ohio
• Dartmouth-Hitchcock Medical Center — Lebanon, Pennsylvania
• University of Vermont Medical Center — Burlington, Vermont
• Brain and Mind Center — Sydney,
• Dept. of Neurology, Medical University of Vienna — Vienna,
• International Centre for Diarrhoeal Disease Research — Dhaka,
• Clínica AMO — Salvador,
• The Ottawa Hospital — Ottawa,
• Aarhus University Hospital — Aarhus,
• Hôpital Percy — Clamart,
• CHU Dupuytren — Limoges,
• Center for Molecular Medicine — Cologne,
• University of Larissa — Larissa,
• "Saint Andrew's" State General Hospital — Pátrai,
• San Gerardo Hospital — Monza, Mb
• Ospedale Valduce — Como,
• Ospedale Policlinico San Martino — Genova,
• A.O.U. Policlinico "G. Martino" — Messina,
• Padova Hospital — Padova,
• Azienda Ospedaliera Universitaria — Verona,

📞 Contact the Study Coordinator

Phone: + 39 02 6448 8039

Email: guido.cavaletti@unimib.it

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Chemotherapy-induced Peripheral Neuropathy

• The Effect of Electroacupuncture on Nerve Pain Caused by Chemotherapy (Chemotherapy-Induced Peripheral Neuropathy) — Boston, Massachusetts
• NIAGEN and Persistent Chemotherapy-Induced Peripheral Neuropathy — Iowa City, Iowa
• Exercise-based Rehabilitation to Treat Persistent Chemotherapy Induced Peripheral Neuropathy (CIPN) — Toronto, Ontario
• Efficacy and Safety of ATX01 in Adult Patients With CIPN (Chemotherapy-induced Peripheral Neuropathy) — Clermont, Florida
• Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral Neuropathy — Houston, Texas
• PEA for the Relief of Chemotherapy-Induced Peripheral Neuropathy — Middletown, Connecticut

Explore by condition: All Chemotherapy-induced Peripheral Neuropathy clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.